170417 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines Tumor necrosis factor [TNF]
Sub-classes:Activation-dependent immune dysfunction traits enable identification of prodromal Parkinson's
#2CD11B AGONISTS FOR TREATMENT OF AUTOIMMUNE DISEASE
#3Methods and Treatment Involving Excess Free LIGHT
#4METHOD FOR SCREENING AND PREPARING IMMUNOMODULATOR
#5ANAKINRA FOR THE TREATMENT OF POST ACUTE COVID SYNDROME
#6METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#7BIOMARKERS
#8NEUTRALIZATION ANTIBODY ASSAY METHOD
#9METHODS OF DETECTING AND TREATING CEREBRAL ANEURYSMS
#10METHODS FOR DETECTING OR TREATING ATHEROSCLEROSIS
#11METHOD FOR DETECTING ANTI-DRUG ANTIBODIES AGAINST SELF-ASSEMBLING TRIMERIC BIOLOGICS USING AN AFFINITY CAPTURE ELUTION-PROTEIN A/G ASSAY
#12METHODS RELATING TO IMPAIRED RESPIRATORY HEALTH THERAPEUTICS
#13TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#14METHODS FOR EVALUATION OF EXTRACELLULAR VESICLES
#15COMPOSITIONS AND METHODS OF TREATING SEPSIS IN PATIENTS USING ANTI-LIGHT ANTIBODIES
#16TARGET-BINDING ACTIVATED SPLIT REPORTER SYSTEMS FOR ANALYTE DETECTION AND RELATED COMPONENTS AND METHODS
#17EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS
#18MARKERS FOR PROGRESSION OF INFLAMMATORY LIVER DISEASE
#19METHODS OF USING AVERMECTIN COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND DOSING REGIMENS
#20NANOSENSORS AND USE THEREOF
#21COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#22COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEPRESSION
#23METHODS AND DEVICES FOR STORING OR STABILIZING MOLECULES
#24MULTIPLEX CELLULAR ASSAYS FOR SCREENING AND QUALITY ASSESSMENT OF ENGINEERED CELLS
#25MECHANISM OF ACTION
#26METHOD FOR OPTIMIZING DRUG SELECTION
#27COMPOSITION FOR TREATING SOLID MALIGNANT TUMOR, AND KIT FOR TREATING SOLID MALIGNANT TUMOR
#28PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#29EARLY DIAGNOSIS OF INFECTIONS
#30RED BLOOD CELL-DERIVED MAGNETIC IMMUNO-PARTICLE AND USE THEREOF
#31EX VIVO MODEL OF INFLAMED HUMAN SKIN AND USES THEREOF FOR SCREENING ANTI-INFLAMMATORY COMPOUNDS
#32METHOD FOR OBTAINING APRIL-BINDING PEPTIDES, PROCESS FOR PRODUCING THE PEPTIDES, APRIL-BINDING PEPTIDES OBTAINABLE WITH SAID METHOD/PROCESS AND USE OF THE APRIL-BINDING PEPTIDES
#33DEVELOPMENT OF FLEXIBLE PLASMONIC MEMBRANE-BASED SERS PLATFORM FOR MONITORING THE HEALING
#34TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#35VAGUS NERVE STIMULATION PRE-SCREENING TEST
#36DIAGNOSTIC METHODS FOR HIDRADENITIS SUPPURATIVA
#37MESENCHYMAL STEM CELLS EXPRESSING TNF-ALPHA RECEPTORS
#38IMMUNOSTIMULATORY BACTERIA FOR CONVERTING MACROPHAGES INTO A PHENOTYPE AMENABLE TO TREATMENT, AND COMPANION DIAGNOSTIC FOR IDENTIFYING SUBJECTS FOR TREATMENT
#39Cardiovascular Disease
#40DRAIN FLUIDS FOR DISEASE DIAGNOSIS AND MONITORING
#41Blood Test to Screen Out Parkinson's Disease
#42MOLECULAR SIGNATURES OF LONG-TERM COVID-19 AND TREATMENT THEREOF
#43Target-binding activated split reporter systems for analyte detection and related components and methods
#44BATCH RELEASE ASSAY FOR PHARMACEUTICAL PRODUCTS RELATING TO T CELL THERAPIES
#45METHODS OF DIAGNOSING AND PREDICTING RENAL DECLINE
#46METHODS FOR DETERMINING TUMOR IMMUNE STATUS
#47Precision Medicine Approach to Targeting Neurodegeneration
#48ADJUVANT FOR VACCINE DEVELOPMENT
#49METHOD FOR DETERMINING SUITABILITY OF A SUBJECT TO ANTI TNF ALPHA THERAPY
#50TNF-ALPHA AND IL-1ALPHA POSITIVE COPD TREATMENT WITH ANTIBIOTICS
#51CHIMERIC RECEPTOR POLYPEPTIDE AND METHODS OF ACTIVATION THEREOF
#52METHOD FOR DETERMINING WHETHER A SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENT IS UNDERGOING A PRE-FLARE EVENT
#53BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY
#54METHODS AND TREATMENT INVOLVING EXCESS FREE LIGHT
#55CYTOKINE BASED ASSESSMENT OF RECIPIENT ABILITY TO RESPOND TO STEM CELL THERAPY FOR CARTILAGE REGENERATION
#56MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF
#57IMPROVED METHOD AND TEST SYSTEM FOR IN-VITRO DETERMINATION OF DRUG ANTIBODIES IN BLOOD
#58POTENCY ASSAY
#59DETECTING SEPSIS
#60METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#61MODULATOR ASSAY
#62High-affinity peptide for tumor necrosis factor alpha and application thereof
#63PLASMON-ENHANCED FLUORO-DOT ASSAYS
#64Biomarker of gingivitis diagnosis and treatment
#65METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#66METHODS AND KITS FOR DIAGNOSING MILD COGNITIVE IMPAIRMENT
#67Methods of prognosis and treatment
#68IMMUNITY MECHANISM AND THERAPEUTIC DRUG FOR GASTROINTESTINAL DISEASES
#69Early diagnosis of infections
#70Biomarkers and methods for detection of seizures and epilepsy
#71SELECTION OF T CELL RECEPTORS
#72BIOMARKERS FOR DIAGNOSIS OF OCULAR DISEASES AND THE METHOD THEREOF
#73Nanosensors and use thereof
#74METHODS AND ASSAYS FOR IMMUNE PHENOTYPING
#75USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#76Compositions and Methods to Detect Non-Coeliac Gluten Sensitivity
#77Methods of use of anti-TNFα antibodies
#78Vagus nerve stimulation pre-screening test
#79Protein signatures for distinguishing between bacterial and viral infections
#80BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#81Method for diagnosis and subtyping of adult onset Still's disease
#82Methods of Treating an Autoimmune Disease with a Human Interleukin-3 (IL-3)-Diphtheria Toxin Conjugate (DT-IL3)
#83COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#84Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a sample
#85ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
#86Method of treating acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) associate with COVID-19 by administering an anti-LIGHT antibody
#87Materials and Methods for Improved Prediction of IGG Therapeutic Protein Exposure
#88SIMULTANEOUS DETECTION OF HUMORAL AND INFLAMMATORY BIOMARKERS
#89Methods for determining concentration of low and high concentration proteins in a single sample
#90TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseases
#91Methods of immunotherapy
#92METHOD FOR DIAGNOSING LIVER DISEASES AND METHOD FOR SCREENING THERAPEUTIC AGENT FOR LIVER DISEASES USING CHANGES IN EXPRESSION OF TM4SF5 PROTEIN
#93METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#94Mesenchymal stem cells expressing TNF-α receptors
#95Methods and kits for determining tuberculosis infection status
#96A THREE-PROTEIN PROTEOMIC BIOMARKER FOR PROSPECTIVE DETERMINATION OF RISK FOR DEVELOPMENT OF ACTIVE TUBERCULOSIS
#97MECHANISM OF ACTION
#98ANTIBODY
#99Method of identifying potential inhibitors of APO TNFα trimers
#100Treatment of cancers using PI3 kinase isoform modulators
#101METHOD AND KIT FOR ASSISTING DIAGNOSIS OF DISEASE IN SUBJECT
#102METHODS AND KITS FOR EVALUATING CLINICAL OUTCOMES OF AUTOIMMUNE DISEASE
#103Method for quantitatively determining a therapeutic TNF-alpha inhibitor
#104Method for identifying a modulator of the TNFα or CD40L interaction with their cognate receptors
#105Diagnosis and risk stratification of fungal infections
#106ASTROCYTE EXOSOME COMPLEMENT-BASED ASSAY FOR NEUROINFLAMMATION IN ALZHEIMER'S DISEASE AND USES THEREOF
#107Target-binding activated split reporter systems for analyte detection and related components and methods
#108METHODS FOR EVALUATION OF THE EFFECTIVENESS OF A DRUG OR DRUG CANDIDATE IN TREATING AN INFLAMMATORY BOWEL DISEASE BY USE OF A MULTIPLEXED ASSAY KIT COMPRISING VARIOUS BIOMARKERS
#109Biomarkers and methods for detection of seizures and epilepsy
#110ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#111Biomarkers related to organ function
#112Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment
#113Diagnostic, prognostic, and monitoring methods for solid tumor cancers
#114METHOD FOR EVALUATING EFFECT OF CYTOKINE ON METABOLIC ACTIVITY OF CYTOCHROME P450, AND DRUG SCREENING METHOD
#115METHODS FOR MONITORING VEDOLIZUMAB TREATMENT
#116Betaretrovirus epitopes and related methods of use
#117METHODS FOR DIAGNOSING AND TREATING CACHEXIA
#118ANTI-OX40 ANTIBODIES AND METHODS OF USE THEREOF
#119Methods of diagnosing and predicting renal disease
#120Materials and methods for subjects at risk for viral reactivation
#121COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#122Biomarker Panel For Diagnosing Cancer
#123METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#124COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#125Compositions and methods for treating chemosensory dysfunction
#126Methods of prognosis and treatment
#127METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#128Early diagnosis of infections
#129Methods of risk assessment and disease classification for appendicitis
#130Assay for detecting TH1 and TH2 cell populations
#131Therapeutic intervention for osteoporosis
#132Methods for performing ex vivo diagnostic tests for the presence of a proliferation-inducing ligand (APRIL) in a human sample
#133COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#134DETECTING SEPSIS
#135METHODS AND DEVICES FOR STORING OR STABILIZING MOLECULES
#136Method for identifying a bacterial infection
#137Protein signatures for distinguishing between bacterial and viral infections
#138Chemically patterned microfluidic paper-based analytical device (C-μPAD) for multiplex analyte detection
#139BIOMARKERS
#140METHODS RELATED TO ADALIMUMAB
#141IL-22BP AS BIOMARKER IN ANTI-TNF-ALPHA-TREATMENTS
#142Method of monitoring the efficacy of the anti-clever-1 therapy in cancer
#143Vagus nerve stimulation pre-screening test
#144BIOLOGICAL MATERIALS AND USES THEREOF
#145Method for detecting analyte concentration
#146Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis
#147ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS OF REGULATING IRON METABOLISM
#148Compositions and methods to detect non-coeliac gluten sensitivity
#149SYSTEM, METHOD AND COMPUTER PROGRAM PRODUCT FOR THE ORGANISM-SPECIFIC DIAGNOSIS OF SEPTICEMIA IN INFANTS
#150Methods and kits for determining tuberculosis infection status
#151CONSTRUCTION METHOD OF CELL MODELS FOR DETECTING PYROGENS, CELL MODELS AND PYROGEN DETECTION KITS
#152S100A9 levels for predicting lenalidomide and erythropoietin responsiveness
#153Kit for immunological detection of TNF-alpha, sTNFR1 and IL-8 in prostate cancer
#154Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds
#155Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers
#156Methods of identifying signaling modulators of the trimeric TNFa
#157TNF receptor signaling modulator assay
#158Antibodies binding to trimeric TNF alpha epitopes
#159Target-binding activated split reporter systems for analyte detection and related components and methods
#160Complexes between anti-TNF antibodies, trimeric TNF proteins and organic molecules binding them
#161METHODS OF TREATING WITH TUMOR MEMBRANE VESICLE-BASED IMMUNOTHERAPY AND PREDICTING THERAPEUTIC RESPONSE THERETO
#162NOVEL DESIGN OF ENZYME-LINKED IMMUNOSORBENT ASSAY PLATES AND SYSTEMS AND METHODS OF USE THEREOF
#163BIOMARKER FOR PSYCHIATRIC AND NEUROLOGICAL DISORDERS
#164MESENCHYMAL STEM CELLS EXPRESSING TNF-ALPHA RECEPTORS
#165Biomarker panel for diagnosing cancer
#166PUMA, A PRO-APOPTOTIC GENE, AS A NOVEL MOLECULAR BIOMARKER FOR TNFALPHA-INDUCED HUMAN ISLET DAMAGE
#167Biological Materials and Uses Thereof
#168Methods for evaluation of the effectiveness of a drug or drug candidate in treating an inflammatory bowel disease by use of multiplexed assay kit comprising various biomarkers
#169TREATMENT OF CANCERS USING PI3 KINASE ISOFORM MODULATORS
#170Methods of diagnosing and predicting renal disease
#171Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies
#172Method for assessing therapeutic effect of anti-cancer agent having anti-CD4 antibody as active ingredient
#173METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#174Bioassay for the early detection of autoimmune diseases
#175METHODS FOR DOSING AND MONITORING SMAD7 ANTISENSE OLIGONUCLEOTIDE TREATMENT USING BIOMARKER LEVELS
#176METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#177MONOVALENT BINDING PROTEINS
#178METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#179Human exhaled aerosol droplet biomarker system and method
#180Assays for detecting neutralizing autoantibodies to biologic therapy
#181Method for treating melanoma
#182Method to optimize the treatment of patients with biological drugs
#183Two-dimensional material-based field-effect transistor sensors
#184NOVEL CRYSTAL STRUCTURE AND LIGAND BINDING SITES OF TRAIL RECEPTOR
#185Assay for detecting Th1 and Th2 cell populations
#186Method for treating muscular dystrophy
#187Method for diagnosing sleep apnea by measuring adipsin and betatrophin levels
#188Biomarker panel for assessment of mucosal healing
#189Compositions and methods for modulating an immune response
#190Immune monitoring to predict and prevent infection
#191Herbal Combinations for Treating Eczema
#192REDUCTION OF TRAF1 LEVELS COMBINED WITH NUTRIENT STRESS FOR TREATING LYMPHOCYTE-RELATED CANCERS
#193SIGNALING PATHWAYS IN TISSUES FROM INFLAMMATORY BOWEL DISEASE PATIENTS
#194Reconstituted nipple skin model
#195USE OF NUCLEIC ACID AGENTS FOR ULTRA-SENSITIVE DIGITAL DETECTION AND QUANTIFICATION OF TARGET MOLECULES
#196Methods for inhibiting HIV or HCV infection by administering TIM-3 binding inhibitors
#197Specific peptide binders to proteins identified via systematic discovery, maturation and extension process
#198Salivary biomarkers for monitoring of type 2 diabetes treatment
#199METHODS AND APPARATUS FOR CONDUCTING MULTIPLE MEASUREMENTS ON A SAMPLE
#200Biomarkers related to organ function
#201PROTECTION OF TCR SIGNALING CHAINS IN CANCER PATIENTS AND ENHANCEMENT OF CAR-T CELL THERAPY
#202Activities of multiple cancer-related pathways are associated with BRAF mutation and predict the resistance to BRAF/MEK inhibitors in melanoma cells
#203Proliferation-inducing ligand (APRIL)-binding peptides
#204Biomarkers for prostate cancer comprising interleukin-8 (IL-8), tumor necrosis factor alpha and soluble tumor necrosis factor-alpha receptor 1
#205ANTI-INFLAMMATORY COMPOSITIONS, METHODS AND USES THEREOF
#206Methods and kits for determining tuberculosis infection status
#207Biomarkers for predicting relapse in multiple sclerosis
#208METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF DISEASES CHARACTERIZED BY VASCULAR LEAK, HYPOTENSION, OR A PROCOAGULANT STATE
#209Suppression of cytokine release and cytokine storm
#210STRESS AND INFLAMMATION BIOMARKER URINE PANEL FOR DAIRY COWS AND BEEF CATTLE
#211Antibody and Cytokine Biomarker Profiling for Determination of Patient Responsiveness
#212Method of screening for a compound for inhibitory activity of FN14-tweak interaction
#213Biomarker for psychiatric and neurological disorders
#214Complexes of types of MHC class II that bind to collagen type II peptides and their use on diagnosis and treatment
#215ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS OF REGULATING IRON METABOLISM
#216Carbohydrate Compounds for Nutritional and Therapeutic Use
#217Markers for determination of patient responsiveness
#218Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies
#219Parasitic biological agents for treatment and prevention of graft versus host disease
#220Biological Materials and Uses Thereof
#221MULTIPHASE MICROARRAYS AND USES THEREOF
#222Biological specimen evaluation methods using cytology and immunology
#223Method for identifying a bacterial infection
#224Process for assessing risk of substance administration
#225Method and kit for cytokine analysis from a human whole blood sample
#226Compostions and methods for treating chemosensory dysfunction
#227Treatment of inflammation using alpha 7 receptor-binding agonists
#228Biomarkers in inflammatory bowel disease
#229Biomarkers for the identification of liver damage
#230Methods for detecting antibodies
#231Method for evaluating effect of cytokine on metabolic activity of cytochrome P450, and drug screening method
#232Diagnosis and risk stratification of bladder cancer
#233NANOMATERIAL-INDUCED CYTOTOXICITY DETECTION COMPOSITION AND KIT, AND NANOMATERIAL-INDUCED CYTOTOXICITY DETECTION METHOD
#234VAGUS NERVE STIMULATION SCREENING TEST
#235Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#236IRHOM2 INHIBITION FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS
#237Biomarker of renal dysfunction
#238DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#239Microfluidic device for generating neural cells to simulate post-stroke conditions
#240Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer
#241Biomarker of renal dysfunction
#242Biomarkers
#243Method for monitoring HIV specific T cell responses
#244SMALL MOLECULE COMPOUNDS FOR TARGETING INFLAMMATORY CONDITIONS
#245PROSTAGLANDIN E2 DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#246Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
#247Biomarkers for Tuberculosis and HIV/AIDS
#248Single Molecule Assays
#249RISK PREDICTORS FOR ADVERSE PERINATAL OUTCOMES
#250Biomarkers for prediction, diagnosis, and monitoring of parkinson's disease
#251Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#252Methods for identifying antibodies with reduced immunogenicity
#253Assays for detecting neutralizing autoantibodies to biologic therapy
#254Induced intercellular communication
#255Human exhaled aerosol droplet biomarker system and method
#256Methods for differentiating between disease states
#257Highly sensitive biomarker panels
#258Method of treating diabetes-related impaired wound healing
#259Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
#260Methods for detecting antibodies
#261Multiphase microarrays and uses thereof
#262Chimeric Receptors and Methods for Identifying Agents Exhibiting an Activity on Type 1 Single Pass Transmembrane Receptors
#263Genes predictive of anti-TNF response in inflammatory diseases
#264METHODS OF IDENTIFYING OBM MODULATORS
#265METHODS FOR DIAGNOSIS OF IMMUNE RESPONSES AGAINST VIRUSES
#266Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
#267System and method based on blood components for estimating human physiological parameters
#268Mesenchymal stem cells expressing TNF-alpha receptors
#269BIOMARKERS FOR IAP INHIBITOR COMPOUNDS
#270TRI-VARIABLE DOMAIN BINDING PROTEINS AND USES THEREOF
#271Bioassay for the early detection of autoimmune diseases
#272Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
#273Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#274Method of Predicting Placebo Non-Response
#275METHODS FOR CREATING OR IDENTIFYING COMPOUNDS THAT BIND TUMOR NECROSIS FACTOR ALPHA
#276Therapeutic Use Of Probiotics
#277BIOMARKERS
#278Method for Predicting the Responsiveness to an Anti-TNF Alpha Antibody Treatment
#279Dual variable domain immunoglobulins and uses thereof
#280Methods and kits for the differential diagnosis of Alzheimer's disease versus frontotemporal dementia and for the diagnosis of frontotemporal dementia, comprising FAS-L and CK 18 as biomarkers
#281EVALUATING THE THERAPEUTIC POTENTIAL OF A GLUCAN
#282MODULATOR ASSAY
#283PUMA, a pro-apoptotic gene, as a novel molecular biomarker for TNFα-induced human islet damage
#284Methods of diagnosing and predicting renal disease
#285TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING AGONISTS
#286SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS
#287Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis
#288Mesenchymal Stem Cells Expressing TNF-alpha Receptors
#289TREATMENT OF INFLAMMATION USING ALPHA 7 RECEPTOR-BINDING CHOLINERGIC AGONISTS
#290Methods and apparatus for conducting multiple measurements on a sample
#291Biomarker
#292DOMAIN ANTIBODY CONSTRUCT
#293TNFalpha GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS
#294Highly sensitive biomarker panels
#295ZAP-70 as predictor and modulator of effector function of T cells
#296DIAGNOSTIC TEST
#297Organic Compounds
#298ASSAY
#299Diagnostic and therapeutic tools for diseases altering vascular function
#300Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof